This brand name is authorized in France, Ireland, UK.
The drug ACTONEL COMBI contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
HU2YAQ274O - RISEDRONATE SODIUM HEMI-PENTAHYDRATE
|
|
Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved. |
|
2
|
UNII
H0G9379FGK - CALCIUM CARBONATE
|
|
Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M05BB02 | Risedronic acid and calcium, sequential | M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BB Bisphosphonates, combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FR | Base de données publique des médicaments | 64566299 |
| GB | Medicines & Healthcare Products Regulatory Agency | 132090 |
| IE | Health Products Regulatory Authority | 10603 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.